P1703: ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
C. Udeze,
R. McKenna,
Y. Yang,
K. Evans,
P. Smith,
B. Andemariam
Affiliations
C. Udeze
1 Vertex Pharmaceuticals, Boston
R. McKenna
2 IBM Watson Health, Cambridge
Y. Yang
3 Health Economics & Outcomes Research, Vertex Pharmaceuticals, Boston
K. Evans
2 IBM Watson Health, Cambridge
P. Smith
2 IBM Watson Health, Cambridge
B. Andemariam
4 New England Sickle Cell Institute, Division of Hematology-Oncology, Neag Comprehensive Cancer Center, UCONN Health, University of Connecticut, Farmington, United States of America
